[Clinical trial with rifampicin i.v. 300 and 600 in tuberculosis patients].
D000328:Adult; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D012293:Rifampin
Klinische Prüfung mit Rifampicin i.v. 300 und 600 bei Tuberkulosepatienten.